Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Hydroxyflutamide
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | 2-Hydroxyflutamide; HF; OHF; Flutamide-hydroxide; SCH-16423; Hydroxyniphtholide; Hydroxyniftolide; α,α,α-Trifluoro-2-methyl-4'-nitro-m-lactotoluidide |
Drug class | Nonsteroidal antiandrogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.169.708 |
Chemical and physical data | |
Formula | C11H11F3N2O4 |
Molar mass | 292.214 g·mol−1 |
3D model (JSmol) | |
| |
|
Hydroxyflutamide (HF, OHF) (developmental code name SCH-16423), or 2-hydroxyflutamide, is a nonsteroidal antiandrogen (NSAA) and the major active metabolite of flutamide, which is considered to be a prodrug of hydroxyflutamide as the active form. It has been reported to possess an IC50 of 700 nM for the androgen receptor (AR), which is about 4-fold less than that of bicalutamide.
Compound | RBA |
---|---|
Metribolone | 100 |
Dihydrotestosterone | 85 |
Cyproterone acetate | 7.8 |
Bicalutamide | 1.4 |
Nilutamide | 0.9 |
Hydroxyflutamide | 0.57 |
Flutamide | <0.0057 |
Notes: |
Species | IC50 (nM) | RBA (ratio) | ||||
---|---|---|---|---|---|---|
Bicalutamide | 2-Hydroxyflutamide | Nilutamide | Bica / 2-OH-flu | Bica / nilu | Ref | |
Rat | 190 | 700 | ND | 4.0 | ND | |
Rat | ~400 | ~900 | ~900 | 2.3 | 2.3 | |
Rat | ND | ND | ND | 3.3 | ND | |
Rata | 3595 | 4565 | 18620 | 1.3 | 5.2 | |
Human | ~300 | ~700 | ~500 | 2.5 | 1.6 | |
Human | ~100 | ~300 | ND | ~3.0 | ND | |
Humana | 2490 | 2345 | 5300 | 1.0 | 2.1 | |
Footnotes: a = Controversial data. Sources: See template. |
Antiandrogen | Relative potency |
---|---|
Bicalutamide | 4.3 |
Hydroxyflutamide | 3.5 |
Flutamide | 3.3 |
Cyproterone acetate | 1.0 |
Zanoterone | 0.4 |
Description: Relative potencies of orally administered antiandrogens in antagonizing 0.8 to 1.0 mg/kg s.c. testosterone propionate-induced ventral prostate weight increase in castrated immature male rats. Higher values mean greater potency. Sources: See template. |
AR |
|
||||||
---|---|---|---|---|---|---|---|
GPRC6A |
|
||||||